MMR Doses Given 5 Days Apart in Adults
If an adult receives two MMR doses only 5 days apart, the second dose should be considered invalid and must be repeated at least 28 days after the invalid dose. This is because the minimum interval between MMR doses is 28 days, and doses administered more than 5 days before this minimum interval do not count as valid doses.
Why the Second Dose is Invalid
The minimum interval between MMR doses is 28 days (4 weeks), as consistently stated across all ACIP guidelines for adult immunization 1, 2, 3, 1, 3.
ACIP's general immunization practices specify that vaccine doses administered more than 5 days before the minimum interval should not be counted as valid and must be repeated 4.
While doses given within 4 days of the minimum interval can be counted as valid (a "grace period"), doses given more than 5 days early—such as 5 days apart instead of 28 days—fall outside this acceptable window 4.
What Should Be Done
The adult needs to receive a repeat dose that is properly spaced:
Administer a new dose at least 28 days after the invalid (second) dose 4.
This repeat dose will count as the valid second dose in the series 4.
For example: If dose 1 was given on Day 0 and dose 2 (invalid) on Day 5, the repeat dose should be given no earlier than Day 33 (Day 5 + 28 days).
Clinical Context and Rationale
The 28-day minimum interval exists to ensure adequate immune response 1, 2, 3.
Administering doses too close together can lead to suboptimal immune response due to interference from antibodies generated by the first dose 4.
For adults requiring two MMR doses (healthcare workers, international travelers, students in postsecondary institutions, or those in outbreak settings), both doses must be properly spaced to ensure adequate protection against measles, mumps, and rubella 1, 2, 3, 1, 3.
Common Pitfalls to Avoid
Do not assume the improperly spaced dose provides any protection—it must be repeated 4.
Do not restart the entire series—only the invalid dose needs repeating, with proper spacing from that invalid dose 4.
Maintain accurate documentation to prevent future scheduling errors and avoid unnecessary additional doses that could increase reactogenicity 4.